business

Novo Nordisk lifts 2026 outlook as Wegovy drives growth; shares surge

Investing.com · May 6, 2026, 7:44 AM · Also reported by 4 other sources

Read full story on Investing.com → More top stories

Also covered by

Financial Times Novo Nordisk lifts forecasts after strong demand for Wegovy weight-loss pill MarketWatch Novo Nordisk says the Wegovy pill saw the fastest take-up in weight-loss drug history. CNBC Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance Bloomberg Markets Novo Raises Forecast as Wegovy Pill Fuels Sales

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Novo Nordisk lifts 2026 outlook as Wegovy drives growth; shares surge

Also covered by

More in business